Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy

European Heart Journal

Volumn 19, Issue 1, 1998, Pages 132-138

  Gadler, Fredrik ^a   Linde, C ^a   Darpo B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrioventricular radiofrequency conduction modification; Atrioventricular synchronous pacing; Cardiomyopathy; Hypertrophic

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATRIOVENTRICULAR SYNCHRONOUS PACING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TOLERANCE; FEMALE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RATE; HEART VENTRICLE PACING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; THORAX PAIN;

ADULT; AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED;

EID: 0031939468     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0561     Document Type: Article

References (21)

1. [1] Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophie obstructive cardiomyopathy. Lancet 1992; 339: 1318-23.
2. [2] Fananapazir L, Cannon R, Tripodi D, Panza J. Impact of dual-chamber pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic-blocker therapy. Circulation 1992; 85: 2149-61.
3. [3] Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAvreavey D. Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence of progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-42.
4. [4] Slade A, Sadoul N, Shapiro L et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 1996; 75: 44-9.
5. [5] Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Rydén L. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1996; 27: 1219-24.
6. [6] Fananapazir L, Tracy CM, Leon ML et al. Electrophysiologic abnormalities in hypertrophic cardiomyopathy: a consecutive analysis in 155 patients. Circulation 1989; 80; 1259-68.
7. [7] Fananapazir L, Chang AC, Epstein SE, McAvery D. Prognostic determinants in hypertrophic cardiomyopathy. Circulation 1992; 86; 730-40.
8. [8] Fitzpatrick A, Kourouyan H, Siu A et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and chronic established atrial fibrillation. Am Heart J 1996; 131: 499-507.
9. [9] Kunze KP, Schlüter M, Geiger M, Kuck KH. Modulation of atrioventricular nodal conduction using radiofrequency current. Am J Cardiol 1988; 61: 657-8.
10. [10] Hsia CP, Chen SA, Tsang WP et al. Follow-up of a modified catheter ablation of the atrioventricular junction in patients with tachyarrythmias. Chinese Med J 1992; 50: 370-4.
11. [11] Menozzi C, Brignole M, Gianfranchi L et al. Radiofrequency catheter ablation and modulation of atrioventricular conduction in patients with atrial fibrillation. PACE 1994; 17: 2143-9.
12. [12] Lee M, Morady F, Kadish A, Schmap D, Chin M, Scheinman M. Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentrant tachycardia. Circulation 1991; 83: 827-35.
13. [13] Geelen P, Brugada J, Andries E, Brugada P. New observations on the problem of ventricular fibrillation and sudden death after radiofrequency ablation of the atrioventricular junction (Abstr). PACE 1996; 19: 582.
14. [14] Peters R, Wever E, Hauer R, Wittkampf F, Robles de Medina E. Bradycardia dependent QT prolongation and ventricular fibrillation following catheter ablation of the atrioventricular junction with radiofrequency energy. PACE 1994; 17: 108-12.
15. [15] American Society of Echocardiography Committee on standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Ech 1989; 2: 358-67.
16. [16] Sasson Z, Yock P, Hatle L, Alderman E, Popp R. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988; 11: 752-6.
17. [17] Bruce RA, Hornsen TR. Exercise testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 1969; 11: 371-6.
18. [18] Borg GAV. Perceived exertion; a note on 'history' and methods. Med Sci in Sports 1973; 5: 90-3.
19. [19] Chang AC, McAvery D, Tripodi D, Fananapazir L. Radiofrequency catheter atrioventricular node ablation in patients with permanent pacing systems. PACE 1994; 17: 65-9.
20. [20] Gras D, De Place C, Le Breton H et al. L'importance du synchronisme auriculo-ventricularaire dans le cardiomyopahie hypertrophique obstructive traitee par stimulation cardiaque. Arch Mal Coeur 1995; 88: 215-23.
21. [21] Fenelon G, d'Avila A, Malacky T, Brugada P. Prognostic significance of transient complete atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia. Am J Cardiol 1995; 75: 698-702.